Literature DB >> 31566538

Ketamine as Part of a Multimodal Approach to Postoperative Pain Management.

Denise Stuit1, Cormac O'Sullivan2.   

Abstract

Some surgeries present increased challenges for adequate perioperative pain management, which require innovative methods to prevent development of chronic postsurgical pain (CPSP). Ketamine is an adjunct to traditional pain management methods and is an effective analgesic. The potent antihyperalgesic effects of ketamine represent an interesting option for those searching for multimodal approaches. This case report describes pain management for a 73-year old man scheduled for surgical excision of a sacral chordoma who was at high risk of development of CPSP. The intraoperative pain management plan consisted of T9-10 epidural anesthesia with continuous infusion of ropivacaine and hydromorphone, intravenous low-dose ketamine infusion, and intermittent intravenous hydromorphone boluses for breakthrough pain. Post-operatively the epidural infusion was continued for 4 days. The ketamine infusion rate was decreased on transfer to the intensive care unit and titrated to off by postoperative day 3. An intravenous hydromorphone patient-controlled analgesia pump was available to the patient for breakthrough pain postoperatively. This multimodal approach controlled the patient's pain postoperatively without reported complications. At his 1-year postsurgical follow-up visit, the patient reported some generalized "dull aching pain" that was well controlled with oral ibuprofen. Overall, the patient was satisfied with his pain control, and CPSP did not develop. Copyright© by the American Association of Nurse Anesthetists.

Entities:  

Keywords:  Chronic postsurgical pain; ketamine; postoperative pain management; sacral chordoma

Year:  2017        PMID: 31566538

Source DB:  PubMed          Journal:  AANA J        ISSN: 0094-6354


  1 in total

1.  A Comparison Between the Effectiveness of Ketamine Bolus and Intradermal Lidocaine in Reducing Acute Postoperative Pain.

Authors:  M Fahad Najam; Nusrat Jafri
Journal:  Cureus       Date:  2022-07-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.